Ceftobiprole, a new option for multidrug resistant microorganisms in the outpatient antimicrobial therapy setting

Enferm Infecc Microbiol Clin (Engl Ed). 2022 Aug-Sep;40(7):399-400. doi: 10.1016/j.eimce.2021.05.017.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Cephalosporins* / pharmacology
  • Cephalosporins* / therapeutic use
  • Humans
  • Outpatients*

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • ceftobiprole